Company / Current Liabilities per Share
Ultragenyx Pharmaceutical Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$4.15
FY2025
5-year range
$2.71 / $4.18
FY2021-FY2025
Trend
-0.7%
vs FY2024
Sector context
#46 of 210
Health Care
What the data says
Ultragenyx Pharmaceutical Inc.'s current liabilities per share of $4.15 is higher than 78% of companies in the Health Care sector (FY2025). Current Liabilities per Share has fluctuated over the past 10 years, ranging from $1.55 in FY2016 to $4.18 in FY2024.
Based on SEC 10-K filings.
4.15 in FY2025 with a 5-year CAGR of +4.8%. Top quartile in the Health Care sector.
Increased from $3.99 to $4.15 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +3.3%
- 5-Year CAGR
- +4.8%
- 10-Year CAGR
- -
Sector benchmark
-82.5% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 0.7% year-over-year.
- Ranks #46 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2024.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.15 | -0.7% |
| FY2024 | $4.18 | +4.6% |
| FY2023 | $3.99 | +6.1% |
| FY2022 | $3.77 | +38.8% |
| FY2021 | $2.71 | -17.2% |
| FY2020 | $3.28 | +61.4% |
| FY2019 | $2.03 | +20.0% |
| FY2018 | $1.69 | -1.7% |
| FY2017 | $1.72 | +11.1% |
| FY2016 | $1.55 | +104.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026